Identity verification company CLEAR Secure (NYSE:YOU) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 15.5% year on year to $229.2 million. Its non-GAAP profit of $0.37 per share was 17.8% above analysts’ consensus estimates.
Regional bank Washington Trust Bancorp (NASDAQ:WASH) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 16.2% year on year to $56.69 million. Its non-GAAP profit of $0.56 per share was 20.6% above analysts’ consensus estimates.
A number of stocks jumped in the afternoon session after a broad rally in the semiconductor sector kicked off the new year, driven by continued investor enthusiasm for artificial intelligence (AI).
A number of stocks jumped in the afternoon session after a broad rally in the semiconductor sector kicked off the new year, driven by continued investor enthusiasm for artificial intelligence (AI).
Could CBRE Group be the hidden gem you've been searching for? Our experts break down the company's strengths and weaknesses to help you decide if it's worth your investment.
Automotive technology company Visteon (NYSE:VC) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 6.4% year on year to $917 million. The company’s full-year revenue guidance of $3.78 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $2.15 per share was 1.2% above analysts’ consensus estimates.
Network testing solutions company Viavi Solutions (NASDAQ:VIAV) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 25.6% year on year to $299.1 million. On top of that, next quarter’s revenue guidance ($365 million at the midpoint) was surprisingly good and 22.1% above what analysts were expecting. Its non-GAAP profit of $0.15 per share was 14.2% above analysts’ consensus estimates.
Luxury cruise operator Viking (NYSE:VIK) met Wall Streets revenue expectations in Q3 CY2025, with sales up 19.1% year on year to $2 billion. Its GAAP profit of $1.15 per share was 3.7% below analysts’ consensus estimates.
Financial marketplace platform LendingTree (NASDAQ:TREE) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 18% year on year to $307.8 million. On top of that, next quarter’s revenue guidance ($285 million at the midpoint) was surprisingly good and 7.2% above what analysts were expecting. Its non-GAAP profit of $1.70 per share was 46.8% above analysts’ consensus estimates.
Food distribution company United Natural Foods (NYSE:UNFI) fell short of the markets revenue expectations in Q3 CY2025, with sales flat year on year at $7.84 billion. The company’s full-year revenue guidance of $31.8 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.56 per share was 40.3% above analysts’ consensus estimates.
Ultra low-cost airline Frontier Group Holdings (NASDAQ:ULCC) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.2% year on year to $886 million. Its non-GAAP loss of $0.34 per share was 7.7% above analysts’ consensus estimates.
Online gambling company Super Group (NYSE:SGHC) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 25.7% year on year to $557 million. Its GAAP profit of $0.19 per share was 27.3% above analysts’ consensus estimates.
Global automotive retailer Penske Automotive Group (NYSE:PAG) met Wall Streets revenue expectations in Q3 CY2025, with sales up 1.4% year on year to $7.7 billion. Its non-GAAP profit of $3.23 per share was 5% below analysts’ consensus estimates.
Homebuilding company PulteGroup (NYSE:PHM) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 1.6% year on year to $4.4 billion. Its non-GAAP profit of $2.96 per share was 2.5% above analysts’ consensus estimates.
Animal health products manufacturer Phibro Animal Health (NASDAQ:PAHC) fell short of the markets revenue expectations in Q1 CY2026, with sales flat year on year at $347.8 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.46 billion at the midpoint. Its non-GAAP profit of $0.63 per share was 8.3% below analysts’ consensus estimates.
Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) reported Q3 CY2025 results topping the market’s revenue expectations, but sales fell by 5.7% year on year to $14.54 million. Its non-GAAP loss of $0.38 per share was 9.6% below analysts’ consensus estimates.
Midwest regional bank Old Second Bancorp (NASDAQ:OSBC) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 34.6% year on year to $96.22 million. Its non-GAAP profit of $0.53 per share was 4.6% above analysts’ consensus estimates.
